TY - JOUR T1 - Performance and safety of induced sputum procedure in young children in Malawi: a prospective study JF - medRxiv DO - 10.1101/2021.08.12.21261823 SP - 2021.08.12.21261823 AU - Wongani WN Nyangulu AU - Herbert HT Thole AU - Angella AC Chikhoza AU - Mike MM Msakwiza AU - James JN Nyirenda AU - Mphatso MC Chisala AU - Pui-Ying P-YIT Iroh Tam Y1 - 2021/01/01 UR - http://medrxiv.org/content/early/2021/08/18/2021.08.12.21261823.abstract N2 - Background Collecting sputum specimens are a challenge in infants and young children. We assessed performance and safety of induced sputum (IS) collection in this population, embedded in a prospective study evaluating respiratory cryptosporidiosis in Malawian children with diarrheal disease.Methods We assessed sputum quality and correlation with detection of cryptosporidium, and evaluated safety and adverse events in 162 children.Results Among 159 stool specimens tested, 34 (21%, 95% CI 15.0 – 28%) were positive for Cryptosporidium spp. There were160 IS and 161 nasopharyngeal (NP) specimens collected. The majority of IS specimens 122/147 (83%) were clear in appearance, and 132/147 (90%) were of good quality. Among the respiratory specimens tested, 10 (6.3%, 95% CI 2.5 - 10) IS and 4 (3% (95% CI 0 – 5)) NP were positive for Cryptosporidium spp. When stool cryptosporidium PCR was the gold standard, IS PCR sensitivity was higher (29 %, 95% CI 22 – 37) compared to NP PCR (12%, 95% CI 7 – 17) for detection of Cryptosporidium spp. One (0.4%) adverse event occurred, a drop in oxygen saturations at 30-minute post procedure evaluation. Consciousness – level, median respiratory rate and oxygen saturations were unchanged, before or after IS.Conclusions IS provides good quality specimens, is more sensitive than NP specimens for diagnosis of respiratory cryptosporidiosis, and collection can be done safely in children hospitalized with diarrheal disease.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialThis manuscript reports findings from a sub-study of a prospective observational longitudinal study titled, “Evaluating respiratory cryptosporidiosis in pediatric diarrheal disease: protocol for a prospective, observational study in Malawi”. The main longitudinal study was not a clinical trial and as such not registered in an internationally recognized trial registry. It has been published as a pre-print under the following ID and DOI: “medRxiv 2021.05.07.21256838; doi: https://doi.org/10.1101/2021.05.07.21256838”.Funding StatementThis work was supported by The Bill and Melinda Gates Foundation (0PP1191165).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The College of Medicine Research Ethics Committee (COMREC) (P.07/18/2438) and the Liverpool School of Tropical Medicine Research Ethics Committee (18-066) approved the main study. Written informed consent was obtained from parents and guardians of patients before any study procedure and the appropriate institutional forms have been archived.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData will be made available upon reasonable request to the primary study principal investigator (P-YIT). ER -